Neoadjuvant Combination Immunotherapy for Stage III Melanoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neoadjuvant Combination Immunotherapy for Stage III Melanoma	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, cutaneous melanoma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm	Recruiting	Phase 2	2024-05-02		NCT03842943

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Louisville	62

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Louisville	Louisville	United States	83

Clinical trials